Mathematical Modeling of Vedolizumab Treatment's Effect on Microbiota and Intestinal Permeability in Inflammatory Bowel Disease Patients.

Bioengineering (Basel) · 2024 · PMC11274165 · PMID 39061792

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a decreasing trendno p-value reported

Particularly, in UC patients, both RHI and PMS exhibit a decreasing trend over time, suggesting a positive effect of Vedolizumab therapy, as depicted in Figure 9 .

also in 47,180 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.